PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-orpha-predisposition-eu-pcsp | Version: 0.2.0 | |||
Draft as of 2025-09-03 | Computable Name: OrphaHereditaryPredisposition |
Hereditary Predispositions (Orphacode)
References
This value set includes codes based on the following rules:
https://www.orpha.net
Code | Display |
84 | Fanconi anemia |
100 | Ataxia telangiectasia |
109 | Bannayan-Riley-Ruvalcaba syndrome |
116 | Beckwith-Wiedemann syndrome |
122 | Birt-Hogg-Dube´ syndrome |
125 | Bloom syndrome |
144 | Lynch Syndrome |
145 | Hereditary breast and ovarian cancer syndrome |
201 | Cowden Syndrome |
321 | Multiple osteochondromas |
347 | Frasier syndrome |
373 | Simpson-Golabi-Behmel syndrome |
377 | Gorlin syndrome |
500 | LEOPARD syndrome |
523 | Hereditary leiomyomatosis and renal cell cancer |
524 | Li-Fraumeni Syndrome |
587 | Muir Torre syndrome |
618 | Familial Melanoma |
637 | Neurofibromatosis type 2 |
647 | Nijmegen breakage syndrome |
648 | Noonan syndrome |
652 | Multiple endocrine neoplasia type 1 |
653 | Multiple endocrine neoplasia type 2 |
654 | Nephroblastoma |
660 | Omphalocele |
676 | Hereditary chronic pancreatitis |
733 | Familial adenomatous polyposis |
744 | Proteus syndrome |
805 | Tuberous sclerosis complex |
811 | Shwachman-Diamond syndrome |
821 | Sotos syndrome |
870 | Down syndrome |
881 | Turner syndrome |
892 | von Hippel-Lindau syndrome |
893 | WAGR syndrome |
902 | Werner syndrome |
906 | Wiskott-Aldrich syndrome |
910 | Xeroderma pigmentosum |
1331 | Familial prostate cancer |
1340 | Cardio-Facio-Cutaneous (CFC) syndrome |
1359 | Carney Complex |
1572 | Common variable immune deficiency |
1915 | Fetal alcohol syndrome |
2128 | Isolated Hemihypertrophy |
2346 | Angioosteohypertrophic syndrome |
2442 | X-linked lymphoproliferative syndrome |
2678 | Neurofibromatosis type 6 |
2869 | Peutz-Jeghers syndrome |
2909 | Rothmund Thomson syndrome |
2929 | Juvenile polyposis syndrome |
3261 | Autoimmune lymphoproliferative syndrome |
26106 | Hereditary diffuse gastric cancer |
29072 | Hereditary pheochromocytoma-paraganglioma |
44890 | Gastrointestinal stromal tumor |
47044 | Hereditary papillary renal cancer syndrome |
77828 | Genetic obesity |
93460 | Overgrowth syndrome |
97286 | Carney-Stratakis Syndrome |
99817 | Non-polyposis Turcot syndrome |
99818 | Turcot Syndrome with polyposis |
101088 | X-linked hyper-IgM syndrome |
141145 | Hemifacial hyperplasia |
156207 | Macroglossia |
220460 | Attenuated familial adenomatous polyposis |
231040 | Noonan syndrome with multiple lentigines |
231108 | Familial rhabdoid tumor |
251347 | Ataxia-telangiectasia-like disorder |
295049 | Upper limb Hypertrophy |
295051 | Lower limb hypertrophy |
319487 | Familial follicular or papillary thyroid cancer |
331223 | Hyper IgE Syndrome (HIES) |
357027 | Hereditary retinoblastoma |
363700 | Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion |
404560 | Familial atypical multiple mole melanoma syndrome |
423776 | Hereditary gastric cancer |
443909 | Hereditary nonpolyposis colon cancer |
458830 | Rare capillary malformation with associated anomalies |
http://terminology.hl7.org/CodeSystem/v3-NullFlavor
Code | Display | Definition |
OTH | Other | **Description:**The actual value is not a member of the set of permitted data values in the constrained value domain of a variable. (e.g., concept not provided by required code system). **Usage Notes**: This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to \*any\* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE. |
Expansion performed internally based on:
This value set contains 78 concepts
Code | System | Display | Definition |
84 | https://www.orpha.net | Fanconi anemia | |
100 | https://www.orpha.net | Ataxia telangiectasia | |
109 | https://www.orpha.net | Bannayan-Riley-Ruvalcaba syndrome | |
116 | https://www.orpha.net | Beckwith-Wiedemann syndrome | |
122 | https://www.orpha.net | Birt-Hogg-Dube´ syndrome | |
125 | https://www.orpha.net | Bloom syndrome | |
144 | https://www.orpha.net | Lynch Syndrome | |
145 | https://www.orpha.net | Hereditary breast and ovarian cancer syndrome | |
201 | https://www.orpha.net | Cowden Syndrome | |
321 | https://www.orpha.net | Multiple osteochondromas | |
347 | https://www.orpha.net | Frasier syndrome | |
373 | https://www.orpha.net | Simpson-Golabi-Behmel syndrome | |
377 | https://www.orpha.net | Gorlin syndrome | |
500 | https://www.orpha.net | LEOPARD syndrome | |
523 | https://www.orpha.net | Hereditary leiomyomatosis and renal cell cancer | |
524 | https://www.orpha.net | Li-Fraumeni Syndrome | |
587 | https://www.orpha.net | Muir Torre syndrome | |
618 | https://www.orpha.net | Familial Melanoma | |
637 | https://www.orpha.net | Neurofibromatosis type 2 | |
647 | https://www.orpha.net | Nijmegen breakage syndrome | |
648 | https://www.orpha.net | Noonan syndrome | |
652 | https://www.orpha.net | Multiple endocrine neoplasia type 1 | |
653 | https://www.orpha.net | Multiple endocrine neoplasia type 2 | |
654 | https://www.orpha.net | Nephroblastoma | |
660 | https://www.orpha.net | Omphalocele | |
676 | https://www.orpha.net | Hereditary chronic pancreatitis | |
733 | https://www.orpha.net | Familial adenomatous polyposis | |
744 | https://www.orpha.net | Proteus syndrome | |
805 | https://www.orpha.net | Tuberous sclerosis complex | |
811 | https://www.orpha.net | Shwachman-Diamond syndrome | |
821 | https://www.orpha.net | Sotos syndrome | |
870 | https://www.orpha.net | Down syndrome | |
881 | https://www.orpha.net | Turner syndrome | |
892 | https://www.orpha.net | von Hippel-Lindau syndrome | |
893 | https://www.orpha.net | WAGR syndrome | |
902 | https://www.orpha.net | Werner syndrome | |
906 | https://www.orpha.net | Wiskott-Aldrich syndrome | |
910 | https://www.orpha.net | Xeroderma pigmentosum | |
1331 | https://www.orpha.net | Familial prostate cancer | |
1340 | https://www.orpha.net | Cardio-Facio-Cutaneous (CFC) syndrome | |
1359 | https://www.orpha.net | Carney Complex | |
1572 | https://www.orpha.net | Common variable immune deficiency | |
1915 | https://www.orpha.net | Fetal alcohol syndrome | |
2128 | https://www.orpha.net | Isolated Hemihypertrophy | |
2346 | https://www.orpha.net | Angioosteohypertrophic syndrome | |
2442 | https://www.orpha.net | X-linked lymphoproliferative syndrome | |
2678 | https://www.orpha.net | Neurofibromatosis type 6 | |
2869 | https://www.orpha.net | Peutz-Jeghers syndrome | |
2909 | https://www.orpha.net | Rothmund Thomson syndrome | |
2929 | https://www.orpha.net | Juvenile polyposis syndrome | |
3261 | https://www.orpha.net | Autoimmune lymphoproliferative syndrome | |
26106 | https://www.orpha.net | Hereditary diffuse gastric cancer | |
29072 | https://www.orpha.net | Hereditary pheochromocytoma-paraganglioma | |
44890 | https://www.orpha.net | Gastrointestinal stromal tumor | |
47044 | https://www.orpha.net | Hereditary papillary renal cancer syndrome | |
77828 | https://www.orpha.net | Genetic obesity | |
93460 | https://www.orpha.net | Overgrowth syndrome | |
97286 | https://www.orpha.net | Carney-Stratakis Syndrome | |
99817 | https://www.orpha.net | Non-polyposis Turcot syndrome | |
99818 | https://www.orpha.net | Turcot Syndrome with polyposis | |
101088 | https://www.orpha.net | X-linked hyper-IgM syndrome | |
141145 | https://www.orpha.net | Hemifacial hyperplasia | |
156207 | https://www.orpha.net | Macroglossia | |
220460 | https://www.orpha.net | Attenuated familial adenomatous polyposis | |
231040 | https://www.orpha.net | Noonan syndrome with multiple lentigines | |
231108 | https://www.orpha.net | Familial rhabdoid tumor | |
251347 | https://www.orpha.net | Ataxia-telangiectasia-like disorder | |
295049 | https://www.orpha.net | Upper limb Hypertrophy | |
295051 | https://www.orpha.net | Lower limb hypertrophy | |
319487 | https://www.orpha.net | Familial follicular or papillary thyroid cancer | |
331223 | https://www.orpha.net | Hyper IgE Syndrome (HIES) | |
357027 | https://www.orpha.net | Hereditary retinoblastoma | |
363700 | https://www.orpha.net | Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion | |
404560 | https://www.orpha.net | Familial atypical multiple mole melanoma syndrome | |
423776 | https://www.orpha.net | Hereditary gastric cancer | |
443909 | https://www.orpha.net | Hereditary nonpolyposis colon cancer | |
458830 | https://www.orpha.net | Rare capillary malformation with associated anomalies | |
OTH | http://terminology.hl7.org/CodeSystem/v3-NullFlavor | Other | **Description:**The actual value is not a member of the set of permitted data values in the constrained value domain of a variable. (e.g., concept not provided by required code system). Usage Notes: This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE. |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |